0.0800
0.0000
(0.00%)
At close: April 10 at 1:48:02 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-2,032.8060
-2,032.8060
-2,352.7420
-4,462.2320
-3,255.5320
Investing Cash Flow
-67.9000
-67.9000
-17.1270
--
--
Financing Cash Flow
-41.2810
-41.2810
4,039.4840
-34.5510
6,348.3730
End Cash Position
808.9690
808.9690
2,950.9560
1,281.3410
5,778.1240
Interest Paid Supplemental Data
8.7040
8.7040
24.2640
97.0710
75.2350
Capital Expenditure
-67.9000
-67.9000
-17.1270
--
--
Issuance of Capital Stock
--
--
4,600.5710
--
7,000
Repayment of Debt
-1,383.6290
--
-442.2910
--
-515.0800
Repurchase of Capital Stock
--
--
-62.9500
--
-113.3310
Free Cash Flow
-2,100.7060
-2,100.7060
-2,369.8690
-4,462.2320
-3,255.5320
6/30/2021 - 2/22/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BTC.AX BTC Health Limited
0.0500
0.00%
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0350
0.00%
TRP.AX Tissue Repair Ltd
0.2350
-4.08%
RNV.AX RENERVE FPO [RNV]
0.1100
-4.35%
ANR.AX Anatara Lifesciences Ltd
0.0060
0.00%
CMB.AX Cambium Bio Limited
0.2800
0.00%
1AI.AX Algorae Pharmaceuticals Limited
0.0050
0.00%
AVE.AX Avecho Biotechnology Limited
0.0050
0.00%
BGT.AX Bio-Gene Technology Limited
0.0310
0.00%